2853 results about "Bitter taste" patented technology

The invention provides a high throughput, high purity, high yield system and method of isolating and purifying rebaudioside A (“Reb A”), with acceptable water solubility for all commercial uses, from commercially available Stevia rebaudiana starting material. The invention also provides a means of maximizing yields of 99+% purity Reb A based on the attributes of a given batch of Stevia starting material. The Reb A produced by the invention is water soluble, devoid of bitterness heretofore associated with rebaudioside sweeteners, non-caloric, and suitable for use as a reagent and as an ingredient in orally consumed products, e.g., as a sweetener, flavor enhancer, and flavor modifier.

Highly purified Stevioside and Rebaudioside A were prepared from sweet glycoside extracts obtained from Stevia rebaudiana Bertoni leaves. The resulting sweeteners are suitable as non-calorie, non-cariogenic, non-bitter, non-lingering sweeteners, which may be advantageously applied in foods, beverages, and milk products.

Sweeteners on the basis of a simultaneously transglucosylated sweet glycoside mixture of Stevia rebaudiana Bertoni are prepared. The transglycosylation was developed in the presence of starch under the action of cyclodextrin glucanotransferase. The remaining maltodextrins are transferred to the fructose-terminated oligosaccharides. The sweeteners are purified to not less than 98% content of sweet glycosides and derivatives. The preparations are almost non-caloric, non-cariogenic, non-bitter, non-lingering sweeteners, which may be advantageously applied in foods, beverages, cosmetics and milk products.

A sweetener containing a Stevia-derived sweet substance is provided that, while containing cyclodextrin only in small amounts, can mask the bitter taste inherent in the Stevia-derived sweet substance.

Cyclodextrin with a particle size of less than or equal to 30 μm is blended into the Stevia-derived sweet substance at 0.5 to 20 mass % with respect to the mass of the Stevia-derived sweet substance.

The Sensory Smoking Simulator (5) performs by means of suction to draw smoke (33) from a cigarette (21a), only a small amount of which is smelled by the user (39). It is a main body (40) that includes an air motor (12) and a vacuum pump impellers (29) operating in two separate sections (41 and 42). The lower section (42) has a window (10) to connect with the ambient air and a mouthpiece (15) that yields a bitter taste. Means is provided so that when a person (39) inhales, air is draw into the lower section (42) and through the mouthpiece (15). The upper section chamber (41) has a cigarette receiver (24) and two passageways attached, one of them (35) to exhaust the cigarette smoke to ambient air, the other one (30) to let exhaust a lesser amount of smoke (33s) near the user's nose (31). The smell from cigarette smoke (33s) and the taste secreted from the mouthpiece (15) create a mental effect similar to that of smoking, but far less harmful to a person's health.

The present invention provides pharmaceutical compositions comprising azelastine, or a pharmaceutically acceptable salt or ester thereof including azelastine hydrochloride, and optionally one or more additional active agents. Preferred such compositions further comprise one or more pharmaceutically acceptable carriers or excipients that reduce the amount of post-nasal drip, and/or that minimize or mask the unpleasant bitter taste associated with post-nasal drip, of the compositions into the oral cavity, upon intranasal or ocular administration of the compositions. Especially effective excipients used in the compositions of the present invention are hypromellose as a viscosity modifier and sucralose as a taste-masking agent. The invention also provides methods of treating or preventing certain disorders, or symptomatic relief therefrom, by administering the compositions of the invention to a patient, e.g., for the symptomatic relief of allergic rhinitis, non-allergic vasomotor rhinitis, allergic conjunctivitis, as well as other disorders. The compositions and methods of the present invention provide significant value in terms of patient acceptability, convenience, and compliance.

A method comprising selection of unbroken whole grain rice that are first washed, or whole grain corn that is first reduced in size, and then making an aqueous slurry that is subsequently wet milled to release all the protein, fat, fiber, and starch components normally held in the structure of the grain. The resulting slurry can be reacted with heat to gelatinize the starch and the subsequent product dried. Also, the heated slurry containing the liberated components can be treated to enzymatic hydrolysis via the process of liquefaction and optionally saccharification, producing whole grain rice milk products having diverse carbohydrate compositions. The whole grain milk products are characterized by a nutritional composition containing substantially all the nutritional components of the whole grain, being an opaque whole milk colloid, having smooth texture versus pulpiness, lacking in all bitterness normally associated with whole grain products, and having a variety of sweetness levels from non-sweet to very sweet.

The present invention provides a composition alleviated in a bitter taste or the like of a medicament. The present invention relates to a composition comprising a basic medicament having an unpleasant taste and polyvinylpyrrolidone and/or copolyvidone; or a method for alleviating an unpleasant taste of a basic medicament having the unpleasant taste by adding polyvinylpyrrolidone and/or copolyvidone. The present invention further provides a composition comprising (1) a basic medicament, (2) polyvinylpyrrolidone and/or copolyvidone, and (3) propylene glycol and/or D-sorbitol; a composition comprising (1) a basic medicament, (2) polyvinylpyrrolidone and/or copolyvidone, and (4) an antioxidant; and a composition comprising (1) a basic medicament, (2) polyvinylpyrrolidone and/or copolyvidone, and (5) a colorant or flavor containing a sulfuric acid or sulfurous acid group.

The oral cavity quick dissolving and quick disintegrating freeze dried tablet for children includes at least one medicinal active component and at least one medicinal stuffing, adhesive and other supplementary material. It is loose and porous tablet in network structure and prepared through common freeze drying process. The said medicinal active component may be different children's medicines, such as antibiotic, antipyretic, analgesic, cough stopping and phlegm eliminating medicine, cold medicine, etc. Bitter or excitant medicine may be coated and water insoluble medicine is prepared intofine powder of 50 micron below size for stable dispersion in liquid. The present invention has fast disintegration, no jamming in throat, simple preparation process and low cost.

The present invention relates to taste-masked oral formulations of influenza antivirals. The taste-masked pharmaceutical formulations for oral administration comprise one or more influenza antivirals, at least one taste-masking agent and at least one pharmaceutically acceptable excipient. Further, the taste-masked influenza antiviral formulations of the present invention are provided in the form of dispersible tablets, effervescent tablets, orally disintegrating tablets, chewable tablets, bite-dispersion tablets or the like, wherein the bitter taste of influenza antivirals is masked thereby providing palatable formulations.

The invention discloses a method for preparing collagen peptide from fish scales, which is characterized by comprising the following steps of: 1, taking the fish scales and immersing hydrochloric acid to remove calcium; washing to be neutral, drying and crushing; 2, adding the calcium-removed, dried and crushed fish scales obtained by the step 1 into an enzyme reactor; adding water and mixed protease to extract the collagen peptide; after the extraction, carrying out enzyme deactivation and centrifuging to obtain an enzymolysis solution, wherein the mixed protease is a mixture of neutral protease, papain and flavored protease; and 3, carrying out film concentration on the enzymolysis solution obtained by the step 2; and freezing and drying a concentrated solution to obtain fish scale collagen peptide powder. According to the fish scale collagen peptide obtained by the invention, the neutral protease, the papain and the flavored protease are used for extracting the fish scale collagen peptide by an enzymic method at one step, so that not only can the enzymolysis time (9 hours)be reduced, but also the extracting rate (72.72%) of the collagen peptide is improved, and solves the special flavor problem of bitter taste of the collagen peptide and the like.

The invention relates to a preparation method of freeze-drying ginkgo fruit, which mainly comprises the following steps of: scalding gingkoes with testa removed; removing endotesta; subjecting the gingkoes to treatments of debitterizing, curing, secondary cooking in sugar, and sugaring; freezing and drying the gingkoes in vacuum to reach the water content of less than 3% and the sugar content of 9-15% in the product; and finally adopting deoxidized packaging to obtain a freeze-drying ginkgo fruit product. As the raw materials are subjected to the debitterizing, curing and color protection treatments in the invention, the bad bitter taste of internal buds in the gingkoes is overcome, the appearance, shape and color of gingko nutlet are kept unchanged, and the crispness and hardness of the product are increased. As the secondary cooking in sugar and the sugaring are performed, nutrient components of the product are increased, and the palatability of the product is improved; the water content is lower than 3% at the same time as the biological active components in the gingko nutlet are preserved to the maximum extent due to the freezing and drying of the gingkoes in vacuum; therefore, the preparation method is suitable for preserving the product; moreover, the freeze-drying ginkgo fruit is suitable for people to carry and have in leisure and a trip.

A composition comprising cefuroxime axetil in particulate form, the particles being coated with integral coatings of a lipid or mixture of lipids which are insoluble in water in which the composition further comprises a sweetener system and a texture modifier which serves to mask the bitter taste of cefuroxime axetil upon oral administration is disclosed.

The invention discloses an extractive of discoloring, debitterizing corsvenor momordica fruit and a preparation method thereof, the method is as follows: the corsvenor momordica fruit is cleaned, crushed and extracted to juice, the fruit juice is centrifugated, the supernatant fluid enters into the macroporous absorption resin, the resin is washed by water, alkali solvent and water in order, till the effluent liquid is neutral; and then is eluted by 30 percent -65 percent ethanol, the ethanol eluent is collected, ethanol is recovered and dried, and then the extractive is obtained. The technology is simple, the production cost is low, and the production is easy to control; the traditional heating extracting method is replaced by extracting the juice, so the energy consumption is reduced, the color of the obtained extractive is light, the impurity is little, and the product quality is better; the adopted absorption resin achieves better discoloring, debitterizing effects at the same time of enriching the active components completely, the content of momordica glycosides is improved, the pigment and the impurity in the extractive are removed completely through eluting; the obtained product is white powder, the taste is sweet and pure, without traditional bitter taste, wherein, the gypenosides weight content of momordica glycosides can reach over 90 percent, and the V weight content of momordica glycosides can reach over 60 percent.

The present invention provides pharmaceutical compositions comprising azelastine, or a pharmaceutically acceptable salt or ester thereof including azelastine hydrochloride, and optionally one or more additional active agents. Preferred such compositions further comprise one or more pharmaceutically acceptable carriers or excipients that reduce the amount of post-nasal drip, and/or that minimize or mask the unpleasant bitter taste associated with post-nasal drip, of the compositions into the oral cavity, upon intranasal or ocular administration of the compositions. Especially effective excipients used in the compositions of the present invention are hypromellose as a viscosity modifier and sucralose as a taste-masking agent. The invention also generally relates to pharmaceutical compositions comprising one or more active pharmaceutical ingredients, such as azelastine or pharmaceutically acceptable salts or esters thereof including azelastine hydrochloride, particularly wherein the compositions are provided in unit dosage form. In certain embodiments, the invention provides such unit dosage pharmaceutical compositions comprising azelastine hydrochloride formulated for use as nasal sprays and/or ocular solutions or drops. The invention also provides methods of treating or preventing certain disorders, or symptomatic relief therefrom, by administering the compositions of the invention to a patient, e.g., for the symptomatic relief of a variety of allergic and non-allergic conditions, particularly conjunctivitis, sinusitis, rhinitis and rhinosinusitis. The compositions and methods of the present invention provide significant value in terms of patient acceptability, convenience, and compliance.

The invention discloses a walnut low molecular weight polypeptide and a preparation method thereof. The preparation method comprises the following steps: hydrolyzing walnut albumen powder through a high static pressure technique combined with a biological enzyme; decoloring and adsorbing to remove bitter substances in the walnut low molecular weight polypeptide, and then preparing the walnut low molecular weight polypeptide with high purity, good quality and high low molecular weight peptide proportion; and directly packaging or carrying out freeze drying to obtain the finished walnut low molecular weight polypeptide product. The walnut low molecular weight polypeptide disclosed by the invention can be widely applied to medicine raw materials, medicaments, food, health care products, foodadditives and the like. By using the method disclosed by the invention, the hydrolysis degree of protein is improved so that the proportion of the walnut low molecular weight polypeptide is improved,thereby being more beneficial to the absorption and utilization of walnut polypeptide, enhancing the nutrition and health care effects of walnut and improving the product additional value of walnut. Thus, the walnut low molecular weight polypeptide has a good market application prospect.

The invention discloses a new Chinese medicinal composition for treating the symptom of gallstones and a preparation method thereof. The Chinese medicinal composition mainly comprises the following raw material medicaments: pangolin scales, immature bitter orange, curcuma aromatica, green tangerine peel, chicken's gizzard-membrane, peach seed, safflower, common burreed rhizome, zedoary, rhizoma corydalis, frankincense, myrrh, dragon's blood, Chinese honeylocust spine, root of red-rooted salvia, sappan wood, dried lacquer, turtle shell, rhubarb, Chinese dwarf cherry seed, golden thread, honeysuckle, artemisia capillaries, longhairy antenoron herb, pantain seed, talc and Japanese climbing fern spore. The Chinese medicinal composition of the invention can be prepared into any common oral administration preparation according to the conventional method of Chinese medicinal preparations. The Chinese medicinal composition can improve symptoms such as pain, paroxysmal aggravation, abdominal distension, bitter taste, constipation, yellow urine, ictericsclera, yellow body and the like which are caused by gallstones obviously, call away the gallstones, bile duct stones and stones in intrahepatic bile ducts, and has the definite clinical curative effect and obvious curative effect on the treatment of cholecystitis. The Chinese medicinal composition has the advantages of low cost, no toxic or side effect basically and the like.